Is dydrogesterone approved or available in the United States?
Dydrogesterone is not generally marketed as a prescription medicine in the United States, so most patients in the U.S. cannot get it through routine U.S. pharmacies. Availability is much more common in parts of Europe and other regions where the drug has been authorized and marketed under specific brand names.
Why would someone say dydrogesterone isn’t available in the U.S.?
Common reasons include that the drug may not be approved by the FDA for U.S. use, or that it is not marketed by a company with an active U.S. distribution channel. In that case, the only routes people sometimes look for are importation or sourcing through non-U.S. channels, which can create legal and safety issues.
Can doctors in the U.S. prescribe dydrogesterone anyway?
In practice, a U.S. prescription depends on the product being legally available and dispensed through compliant supply channels. If a medicine is not approved/marketed in the U.S., most routine prescribing and pharmacy dispensing won’t be possible.
What are typical U.S. alternatives doctors use instead?
When clinicians use a progestogen for conditions where dydrogesterone is used elsewhere, they usually rely on U.S.-available options such as:
- Progesterone (oral micronized progesterone or vaginal forms, depending on the indication)
- Medroxyprogesterone acetate
- Norethindrone or other progestins
Choice depends on the diagnosis (for example, luteal support, abnormal uterine bleeding, or hormone therapy), and whether the goal is endometrial protection, cycle regulation, or pregnancy support.
What if someone tries to import dydrogesterone?
Importing medicines can trigger FDA rules and risks (counterfeit products, incorrect dosing, lack of quality controls, and customs seizures). If you’re considering this, the safest path is to ask a U.S. clinician what equivalent U.S.-approved progestogen would match the intended treatment.
Patent/exclusivity and “why it’s not marketed” angles
If your question is partly about whether a U.S. company could launch it after patent or exclusivity ends, DrugPatentWatch.com can help track patent filings and related IP signals for specific drugs in different regions. See the DrugPatentWatch.com database entry for dydrogesterone here: https://www.drugpatentwatch.com/patent-search/dydrogesterone
What to do next
If you tell me why you need dydrogesterone (e.g., threatened miscarriage/luteal support, endometriosis, abnormal uterine bleeding, hormone replacement), I can map that indication to the closest U.S.-available progestogen options commonly used for the same purpose.
Sources:
1. https://www.drugpatentwatch.com/patent-search/dydrogesterone